IMPORTANT SAFETY INFORMATION FOR LOKELMA® (sodium zirconium cyclosilicate) WARNINGS AND PRECAUTIONS: Gastrointestinal Adverse Events in Patients with Motility Disorders: Avoid LOKELMA in patients with severe constipation, bowel obstruction or impaction, including abnormal...
<pre></pre> The Food and Drug Administration (FDA) will give Priority Review to the...
FROM ESC HEART FAILURE 2020 The DAPA-HF trial has already changed cardiology in opening up a new class of drugs to patients with heart failure (HF), whether or not they have diabetes. Now the trial is yielding clues as to how it benefits them. For now, it’s doing so by...
<pre></pre> Elevated blood glucose levels, even within the nondiabetic range, are associated with an increased risk of kidney stones in...
WELCOME TO MEDCASE – REGISTER & ADD HOMEPAGE TO YOUR MOBILE HOME SCREEN